GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (GREY:XLSCF) » Definitions » Price-to-Free-Cash-Flow

Xlife Sciences AG (Xlife Sciences AG) Price-to-Free-Cash-Flow : 404.81 (As of May. 10, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Xlife Sciences AG Price-to-Free-Cash-Flow?

As of today (2024-05-10), Xlife Sciences AG's share price is $34.8138. Xlife Sciences AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09. Hence, Xlife Sciences AG's Price-to-Free-Cash-Flow Ratio for today is 404.81.

The historical rank and industry rank for Xlife Sciences AG's Price-to-Free-Cash-Flow or its related term are showing as below:

XLSCF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1861.11   Med: 2500   Max: 2788.89
Current: 2392.86

During the past 6 years, Xlife Sciences AG's highest Price-to-Free-Cash-Flow Ratio was 2788.89. The lowest was 1861.11. And the median was 2500.00.

XLSCF's Price-to-Free-Cash-Flow is ranked worse than
99.54% of 219 companies
in the Biotechnology industry
Industry Median: 32.53 vs XLSCF: 2392.86

Xlife Sciences AG's Free Cash Flow per Share for the six months ended in Dec. 2023 was $0.90. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.09.

During the past 6 years, Xlife Sciences AG's highest 3-Year average Free Cash Flow per Share Growth Rate was -77.80% per year. The lowest was -77.80% per year. And the median was -77.80% per year.


Xlife Sciences AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for Xlife Sciences AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Price-to-Free-Cash-Flow Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - 2,772.22

Xlife Sciences AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2,772.22

Competitive Comparison of Xlife Sciences AG's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Xlife Sciences AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xlife Sciences AG's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's Price-to-Free-Cash-Flow falls into.



Xlife Sciences AG Price-to-Free-Cash-Flow Calculation

Xlife Sciences AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=34.8138/0.086
=404.81

Xlife Sciences AG's Share Price of today is $34.8138.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xlife Sciences AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Xlife Sciences AG  (GREY:XLSCF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Xlife Sciences AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Xlife Sciences AG (Xlife Sciences AG) Business Description

Traded in Other Exchanges
Address
Talacker 35, Zürich, CHE, 8001
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (Xlife Sciences AG) Headlines